New government-funded guidelines promote a more positive approach to initiating biosimilars and switching from biologic drugs to their biosimilar in hospital settings. The new 2021 guiding principles have been released as part of the Department of Health’s ‘Value in Prescribing’ initiative to promote uptake of biosimilars, updating previous guidance released in 2016. In contrast to ...
Guidance updated for psoriasis biologic switching
By Michael Woodhead
7 Dec 2021